Voyager Therapeutics (VYGR) Profit After Tax Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.23% |
| Dec 31, 2025 | -11.48% |
| Sep 30, 2025 | -18.39% |
| Jun 30, 2025 | -30.91% |
| Mar 31, 2025 | -5.04% |
| Dec 31, 2024 | -22.36% |
| Sep 30, 2024 | 9.63% |
| Jun 30, 2024 | -23.81% |
| Mar 31, 2024 | 16.05% |
| Dec 31, 2023 | 35.11% |
| Sep 30, 2023 | -5.01% |
| Jun 30, 2023 | 2.76% |
| Mar 31, 2023 | 52.42% |
| Dec 31, 2022 | -14.84% |
| Sep 30, 2022 | 22.47% |
| Jun 30, 2022 | -0.22% |
| Mar 31, 2022 | -5.07% |
| Dec 31, 2021 | 19.03% |
| Sep 30, 2021 | -22.82% |
| Jun 30, 2021 | -26.40% |
| Mar 31, 2021 | -24.67% |
| Dec 31, 2020 | -16.94% |
| Sep 30, 2020 | 88.59% |
| Jun 30, 2020 | -17.38% |
| Mar 31, 2020 | -10.73% |
| Dec 31, 2019 | -21.80% |
| Sep 30, 2019 | -30.24% |